This dispensary will be Cresco's sixth Sunnyside location in Illinois
Cresco Labs, one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it has received its special use approval from the Zoning Board of Appeals (the "ZBA") for its dispensary located at 436 N. Clark St. in the prestigious River North neighborhood of Chicago (the "Dispensary"). The Dispensary is one of the two licenses Cresco won in the Central District in Chicago's lottery, as announced on November 15, 2019, and one of the only two city-approved adult-use dispensaries in downtown Chicago to date.
Cresco has licenses to open an additional four dispensaries and has so far announced its intention to open locations in the Gold Coast neighborhood of Chicago, Danville, Il and South Beloit, Il.
"Cresco has a long history of being first to market in new jurisdictions. Our ability to execute quickly and efficiently in a highly regulated, complex industry has always been a core strength of the Company. We are proud to have received zoning approval in another step in the process to open an adult-use dispensary in downtown Chicago," said Charlie Bachtell, Cresco Labs CEO and Co-founder.
"Earning the right to operate in this highly coveted location is both a privilege and a significant opportunity for Cresco.
The Dispensary is minutes from the Magnificent Mile, one of the busiest shopping districts in the United States. On a personal note, it is also minutes from Cresco's corporate headquarters, and I couldn't be more excited about Sunnyside potentially having a flagship dispensary in this neighborhood."
Despite a limited number of dispensaries open across the state and ongoing supply shortages, the Illinois adult-use market is proving to be as robust as forecasted with $74 million in sales during the first two months1. Illinois is expected to be a $2 – $4 billion dollar market at maturity2. To strengthen its leading market share in the Illinois, Cresco is nearing completion of a significant expansion that will bring total cultivation to 243,000 square feet of cultivation and will considerably increase supply to support its dispensaries and wholesale distribution across the state.
Cresco is able to expand its three cultivation facilities to an aggregate total of 630,000 sq. ft. of flowering canopy – the largest capacity footprint allowed in the state3. Cresco currently sells into 100% of licensed dispensaries in Illinois and has maintained its leading market share of wholesale sales in the state.
The final step of the approval process for Cresco's River North Sunnyside Dispensary is an inspection by the State of Illinois Department of Financial and Professional Regulation and being awarded an Adult Use Dispensing Organization License.
To learn more about Cresco Labs visit their Company HQ here.
Disclaimer: Past performance is not an indicator of future performance.
This could be one of the best investing opportunities of 2020
Legislative changes are blowing through the US, and with it, an ever-increasing number of states legalising cannabis for recreational use.
With the success seen in Illinois, which legalised for adult-use on January 1 and saw products moving off the shelf at an unprecedented rate, this company is primed to take advantage of the booming US recreational market.
They have secured partnerships with the biggest cannabis companies in the US, and their portfolio is second to none.
And with the sector-wide pullback of 2019, this company is now at a bargain-basement price.
Get the Latest Marijuana News &
Content in your Inbox!
All your support helps The Green Fund keep writing content for all you
marijuana enthusiasts and potential pot stock investors